Header Logo

Connection

Robin Jones to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Robin Jones has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Robin Jones
Connection Strength
0.246
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. The development and application of imatinib. Expert Opin Drug Saf. 2005 Mar; 4(2):183-91.
    View in: PubMed
    Score: 0.246
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.